Form 4 Filing for Altimmune, Inc. (ALT)

This filing details a grant of 48,800 stock options to Diane Jorkasky, a director at Altimmune, Inc. The options were granted on May 1, 2026, with an exercise price of $2.82 per share and an expiration date of May 1, 2036. These options vest over 12 months, with vesting contingent upon continued service. The options were granted under the company's non-employee director compensation policy. Following this transaction, Ms. Jorkasky holds 48,800 shares underlying these options.